AbbVie (ABBV) Dividend Coverage Ratio Growth (5y) (2018 - 2026)
Powered by 
Analysis
AbbVie (ABBV) Dividend Coverage Ratio Growth (5y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.03 Bn | 625.27 Bn | 17.26 Bn |
| 2 | AbbVie | 441.99 Bn | 435.42 Bn | 12.70 Bn |
| 3 | Merck | 366.30 Bn | 359.16 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.55 Bn | 258.86 Bn | 11.24 Bn |
| 5 | Pfizer | 159.14 Bn | 147.45 Bn | 10.94 Bn |
| 6 | Sanofi | 52.40 Bn | 45.02 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.13 Bn | 44.13 Bn | - |
| 8 | Incyte | 25.53 Bn | 20.99 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.51 Bn | 18.85 Bn | 683.80 Mn |
| 10 | Neurocrine Biosciences | 15.60 Bn | 15.21 Bn | 935.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 28.75% |
| Mar 31, 2026 | -31.80% |
| Dec 31, 2025 | 103.00% |
| Sep 30, 2025 | -43.29% |
| Jun 30, 2025 | 22.57% |
| Mar 31, 2025 | -23.73% |
| Dec 31, 2024 | -14.92% |
| Sep 30, 2024 | -13.65% |
| Jun 30, 2024 | 1.41% |
| Mar 31, 2024 | -20.38% |
| Dec 31, 2023 | 17.60% |
| Sep 30, 2023 | -18.45% |
| Jun 30, 2023 | -9.83% |
| Mar 31, 2023 | -15.04% |
| Dec 31, 2022 | 81.21% |
| Sep 30, 2022 | -0.14% |
| Jun 30, 2022 | -27.67% |
| Mar 31, 2022 | 1.32% |
| Dec 31, 2021 | 3.23% |
| Sep 30, 2021 | -4.32% |